Genetic tests for Alzheimer’s can detect specific genes linked to the disease. In most cases, they can’t definitively confirm or predict a diagnosis, but they can provide insight into your relative ...

Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent"), a technology-based company with a well-established laboratory services ...

Non-invasive embryo genetic testing (niPGT) is a trending procedure that checks for chromosomal abnormalities without a cell ...

There are at least 500 sudden and unexpected deaths in the city each year, and in roughly a fifth of those cases, a genetic cause can be detected.

When the Human Genome Project concluded 21 years ago, it opened the door for genetic testing and a promise for lifesaving screenings and personalized medicine. An innovation that serves as a key ...

Genetic testing plays an important role in cystic fibrosis screening and diagnosis. It can help determine if a person has cystic fibrosis or carries gene mutations that cause it. Other tests can also ...

The medical examiner's office investigates approximately 40,000 deaths per year in New York City. Its molecular genetics laboratory, founded by Dr. Yingying Tang in 2003, is the only one of its kind ...

In a recent blog, I discussed the change in nomenclature for the conditions formerly known as Neurofibromatosis type 2 (NF2) and schwannomatosis. This change was based on the results of an ...

The addition of Bako and StrataDx is anticipated to bolster Fulgent’s lab services business with the inclusion of new ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

Genetic testing for chronic myeloid leukemia (CML) can tell doctors if someone has leukemia, what type they may have, and whether treatment is working. The tests look for atypical changes in certain ...